Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT04080141 Completed - Clinical trials for Post Traumatic Stress Disorder

Therapeutic Termination of Pregnancy and Psychiatric Implications

TTOP_PSY
Start date: January 1, 2012
Phase:
Study type: Observational

25 parental couples, with a prenatal diagnosis of fetal abnormality, had psychiatric evaluation for eligibility before TToP and after one year from the procedure. Women and unborn's fathers were also subjected to different psychometric questionnaires (HAM-D, HAM-A, BDI-II, PCL-5, IPDS, CTQ, CD-RISC-10).

NCT ID: NCT04072809 Completed - Clinical trials for Fetal Alcohol Spectrum Disorders

Dissecting the Genetics of Fetal Alcohol Spectrum Disorders

DiGFASD
Start date: July 6, 2018
Phase:
Study type: Observational

The purpose of this study is to help scientists understand why some people who were exposed to alcohol in the womb have special facial features but other people do not. This study will test if genetics (or DNA) explains these differences. We hope this will help improve treatments and interventions for people with fetal alcohol spectrum disorders (FASD). Participants in this study (or their parents or legal guardians) will be asked to: - Answer some questions about themselves. These questions ask about their demographic background (such as gender, race, ethnicity, income, and education), their health history, and their mother's health during her pregnancy with them (if that information is known). - Speak with study staff briefly by phone or video chat to confirm enrollment in the study and ask any questions they have. - Take photographs of their face. - Provide a saliva sample for genetic research. Participants can complete the study at home from anywhere in the world. The questions can be answered online, over the phone, or on paper. Adopted families are welcome to enroll. The study pays for all shipping costs.

NCT ID: NCT04068467 Completed - Schizophrenia Clinical Trials

Evaluation of mHealth for Serious Mental Illness

Start date: January 6, 2020
Phase: N/A
Study type: Interventional

This study is a waitlist control trial evaluating the acceptability and preliminary efficacy of a smartphone application with people with mental illness.

NCT ID: NCT04066153 Completed - Cancer Clinical Trials

Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions

Start date: August 20, 2019
Phase:
Study type: Observational

Purpose: To determine unmet functional needs in patients referred to the Palliative Care Unit at Rigshospitalet, Copenhagen University Hospital will be asked to fill out self reported questionnaires regarding problem intensity, problem burden and felt needs, physical functioning, emotional functioning, fatigue, sleep, distress. Furthermore patients physical function will be evaluated.

NCT ID: NCT04060940 Completed - Clinical trials for Generalized Anxiety Disorder

Emotion Regulation Therapy for Clinical Worry and Rumination

ERT
Start date: November 6, 2015
Phase: N/A
Study type: Interventional

The present project aims to broaden our understanding of neural mechanisms which may underlie change in symptoms occurring over the course of Emotion Regulation Therapy. Specifically, we aim to examine neural changes as a result of either an 8-session or 16-session version of the treatment.

NCT ID: NCT04060654 Completed - Clinical trials for Opioid Use Disorder, Moderate

SUBLOCADE Rapid Initiation Extension Study

Start date: October 21, 2019
Phase: Phase 4
Study type: Interventional

A single center, open-label SUBLOCADE treatment extension study in which up to 25 participants diagnosed with moderate to severe opioid use disorder (OUD) could be enrolled.

NCT ID: NCT04055363 Completed - Growth Clinical Trials

Human Milk Oligosaccharides (HMOs) Post-market Study on Infants

NEHMO
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Human milk oligosaccharides (HMOs) represent the third largest solid component of breast milk. Technology advancements made it possible to supplement infant formulas with HMOs (2'FL, LNnT). Two published RCTs have demonstrated that infant formulas supplemented with 2'FL or 2'FL+LNnT are safe, well-tolerated, support normal grow, and may support healthy GI function and confer immune benefits. The performance of HMOs-supplemented formulas assessed in a real-world setting is complementary to previously conducted RCTs conducted in highly controlled clinical settings. Main objectives will be to monitor the safety & tolerance of HMOs-supplemented formulas in larger and diverse infant populations; to assess the performance of HMOs-supplemented formulas in mixed-fed infants, a population that was not studied in previous RCTs but likely represents a relatively common feeding regimen. Finally, considering the potential health/immune benefits of HMOs, it is also important explore the incidences of illnesses (i.e., respiratory illnesses, GI illnesses, and fever) associated with consuming HMOs-supplemented formulas and compare with breastfed infants data.

NCT ID: NCT04055181 Completed - Schizophrenia Clinical Trials

Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The investigators investigated the effects of high frequency (10Hz) repetitive transcranial magnetic stimulation (rTMS) on the symptoms and cognitive functioning in patients with psychiatric disorders

NCT ID: NCT04054349 Completed - Clinical trials for Autism Spectrum Disorder

The Effect of the Low Fodmap Diet in Children With Autism Spectrum Disorders

Start date: January 3, 2019
Phase: N/A
Study type: Interventional

This study assesses the effect of the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet on gastrointestinal (GI) and behavioral problems in children with autism spectrum disorder (ASD). The objectives of this study are: -To determine whether the low FODMAP diet causes a decrease in gastrointestinal problems related to ASD -To determine whether the low FODMAP diet causes a decrease in behavioral problems -To assess the effect of decreased gastrointestinal problems on reduction of behavioral problems

NCT ID: NCT04044404 Completed - Kidney Disease Clinical Trials

Application of Ultrasound Integrated Precision Diagnosis Technology in Prevention of Kidney Disease and Its Progress

Start date: April 29, 2019
Phase:
Study type: Observational

In this study, a prospective, randomized and controlled clinical study would be carried out to establish Ultrasound Integrated Precision Diagnosis Technology with elastography as the core technology to evaluate renal injury and repair comprehensively and accurately, and to improve the clinical diagnosis chance of renal injury (or renal fibrosis). Combined with the dynamic changes of biomarkers (inflammatory factors, cytokines secreted by immune cells, etc.) after kidney injury, the research on the prognosis of kidney disease with ultrasound elastography technology as the core would be explored, which aims to provide a scientific basis for the application of Ultrasound Integrated Precision Diagnosis Technology.